Skip to main content

Resource · GDR

Gradual dose reduction documentation template

A one-page structure for a defensible GDR record — the attempt (or documented contraindication), the rationale, the taper, and the prescriber and DON sign-off that closes the loop.

Aligned to CMS F758 (psychotropics / GDR) and ASCP / Beers / STOPP criteria. Guidance only — no CMS or ASCP endorsement; use synthetic data, never PHI.

  1. 1

    Resident identifier

    Use a synthetic "ZZ DEMO" identifier in any shared copy — never real PHI.

  2. 2

    Target medication

    Drug, strength, and route under consideration for reduction.

  3. 3

    Indication & diagnosis

    The documented target symptom and diagnosis the drug is treating.

  4. 4

    Current dose & duration

    Present dose, start date, and time at the current dose.

  5. 5

    GDR history

    Prior reduction attempts — dates, dose changes, and outcomes (tolerated / symptoms recurred).

  6. 6

    Clinical rationale for reduction

    Why reduction is appropriate now — OR a documented clinical contraindication if GDR is deemed inappropriate.

  7. 7

    Target taper schedule

    Proposed step-down (e.g., reduce X mg every N weeks) and the reassessment point.

  8. 8

    Monitoring plan

    Target symptoms, non-pharmacologic supports, and the follow-up interval.

  9. 9

    Prescriber recommendation & e-signature

    Accept / modify / decline with rationale, signed and dated by the prescriber.

  10. 10

    DON acknowledgment

    Director of Nursing acknowledgment and date, closing the loop.

Frequently asked questions

When is a gradual dose reduction (GDR) required?

Under CMS guidance (F758), residents on psychotropics should have GDR attempted in two separate quarters within the first year of admission or initiation (unless clinically contraindicated), and at least annually thereafter. The key is documenting the attempt — or a clear clinical contraindication.

What if GDR is clinically contraindicated?

Document it. A defensible record shows the clinical rationale for why reduction would likely cause harm (e.g., prior attempts led to symptom recurrence), tied to the diagnosis and target symptoms — not a blanket statement.

Do I have to use real patient data?

No. Use synthetic "ZZ DEMO" identifiers in any shared or sample copy. This template is guidance and implies no CMS or ASCP endorsement.

GDR documentation, captured as you review

WeConsult Rx flags overdue GDR attempts and carries the rationale into a dated, e-signed record — see it on a live monthly review.